Literature DB >> 21953454

CRM1 protein-mediated regulation of nuclear clusterin (nCLU), an ionizing radiation-stimulated, Bax-dependent pro-death factor.

Konstantin S Leskov1, Shinako Araki, John-Paul Lavik, Jose A Gomez, Vivian Gama, Efstathios S Gonos, Ioannis P Trougakos, Shigemi Matsuyama, David A Boothman.   

Abstract

Expression of the clusterin (CLU) gene results in the synthesis of a conventional secretory isoform set (pre- and mature secretory clusterin proteins, psCLU/sCLU), as well as another set of intracellular isoforms, appearing in the cytoplasm (pre-nuclear CLU, pnCLU) and in the nucleus as an ∼55-kDa mature nuclear clusterin (nCLU) form. These two isoform sets have opposing cell functions: pro-survival and pro-death, respectively. Although much is known about the regulation and function of sCLU as a pro-survival factor, the regulation and function of endogenous nCLU in cell death are relatively unexplored. Here, we show that depletion of endogenous nCLU protein using siRNA specific to its truncated mRNA increased clonogenic survival of ionizing radiation (IR)-exposed cells. nCLU-mediated apoptosis was Bax-dependent, and lethality correlated with accumulation of mature nCLU protein. nCLU accumulation was regulated by CRM1 because binding between CRM1 and nCLU proteins was significantly diminished by leptomycin B (LMB), and nuclear levels of nCLU protein were significantly enhanced by LMB and IR co-treatment. Moreover, LMB treatment significantly enhanced IR-induced nCLU-mediated cell death responses. Importantly, bax(-/-) and bax(-/-)/bak(-/-) double knock-out cells were resistant to nCLU-mediated cell death, whereas bak(-/-) or wild-type bax(+/+)/bak(+/+) cells were hypersensitive. The regulation of nCLU by CRM1 nuclear export/import may explain recent clinical results showing that highly malignant tumors have lost the ability to accumulate nCLU levels, thereby avoiding growth inhibition and cell death.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21953454      PMCID: PMC3220538          DOI: 10.1074/jbc.M111.252957

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Nuclear localization of cyclin B1 regulates DNA damage-induced apoptosis.

Authors:  Lisa A Porter; I Howard Cukier; Jonathan M Lee
Journal:  Blood       Date:  2002-11-07       Impact factor: 22.113

2.  Synthesis and functional analyses of nuclear clusterin, a cell death protein.

Authors:  Konstantin S Leskov; Dmitry Y Klokov; Jing Li; Timothy J Kinsella; David A Boothman
Journal:  J Biol Chem       Date:  2003-01-24       Impact factor: 5.157

3.  Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis.

Authors:  Haim Y Cohen; Siva Lavu; Kevin J Bitterman; Brian Hekking; Thomas A Imahiyerobo; Christine Miller; Roy Frye; Hidde Ploegh; Benedikt M Kessler; David A Sinclair
Journal:  Mol Cell       Date:  2004-03-12       Impact factor: 17.970

4.  Nuclear clusterin/XIP8, an x-ray-induced Ku70-binding protein that signals cell death.

Authors:  C R Yang; K Leskov; K Hosley-Eberlein; T Criswell; J J Pink; T J Kinsella; D A Boothman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

5.  Clusterin is an ATP-independent chaperone with very broad substrate specificity that stabilizes stressed proteins in a folding-competent state.

Authors:  S Poon; S B Easterbrook-Smith; M S Rybchyn; J A Carver; M R Wilson
Journal:  Biochemistry       Date:  2000-12-26       Impact factor: 3.162

6.  Interaction of a putative BH3 domain of clusterin with anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy.

Authors:  Dong-Hwa Lee; Ji-Hyang Ha; Yul Kim; Kwang-Hee Bae; Jae-Yong Park; Wan Sung Choi; Ho Sup Yoon; Sung Goo Park; Byoung Chul Park; Gwan-Su Yi; Seung-Wook Chi
Journal:  Biochem Biophys Res Commun       Date:  2011-04-19       Impact factor: 3.575

7.  Alterations in the post-translational modification and intracellular trafficking of clusterin in MCF-7 cells during apoptosis.

Authors:  J O'Sullivan; L Whyte; J Drake; M Tenniswood
Journal:  Cell Death Differ       Date:  2003-08       Impact factor: 15.828

8.  Silencing expression of the clusterin/apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress.

Authors:  Ioannis P Trougakos; Alan So; Burkhard Jansen; Martin E Gleave; Efstathios S Gonos
Journal:  Cancer Res       Date:  2004-03-01       Impact factor: 12.701

9.  Nucleotide-based therapies targeting clusterin chemosensitize human lung adenocarcinoma cells both in vitro and in vivo.

Authors:  Laura V July; Eliana Beraldi; Alan So; Ladan Fazli; Kenneth Evans; John C English; Martin E Gleave
Journal:  Mol Cancer Ther       Date:  2004-03       Impact factor: 6.261

10.  Intracellular clusterin causes juxtanuclear aggregate formation and mitochondrial alteration.

Authors:  Laure Debure; Jean-Luc Vayssiere; Vincent Rincheval; Fabien Loison; Yves Le Drean; Denis Michel
Journal:  J Cell Sci       Date:  2003-06-10       Impact factor: 5.285

View more
  10 in total

1.  Involvement of chromosome region maintenance 1 (CRM1) in the formation and progression of esophageal squamous cell carcinoma.

Authors:  Xiaojing Yang; Lei Cheng; Li Yao; Hanru Ren; Shu Zhang; Xiao Min; Xueyu Chen; Jianguo Zhang; Mei Li
Journal:  Med Oncol       Date:  2014-08-23       Impact factor: 3.064

Review 2.  The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases.

Authors:  S Park; K W Mathis; I K Lee
Journal:  Rev Endocr Metab Disord       Date:  2014-03       Impact factor: 6.514

Review 3.  Clusterin: Review of research progress and looking ahead to direction in hepatocellular carcinoma.

Authors:  Peng Xiu; Xiao-Feng Dong; Xin-Ping Li; Jie Li
Journal:  World J Gastroenterol       Date:  2015-07-21       Impact factor: 5.742

4.  Nucleofection of rat pheochromocytoma PC-12 cells with human mutated beta-amyloid precursor protein gene (APP-sw) leads to reduced viability, autophagy-like process, and increased expression and secretion of beta amyloid.

Authors:  Beata Pająk; Elżbieta Kania; Arkadiusz Orzechowski
Journal:  Biomed Res Int       Date:  2015-03-10       Impact factor: 3.411

5.  Non-secreted clusterin isoforms are translated in rare amounts from distinct human mRNA variants and do not affect Bax-mediated apoptosis or the NF-κB signaling pathway.

Authors:  Hans Prochnow; Rene Gollan; Philipp Rohne; Matthias Hassemer; Claudia Koch-Brandt; Markus Baiersdörfer
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

Review 6.  Function, clinical application, and strategies of Pre-mRNA splicing in cancer.

Authors:  Cuixia Di; Qianjing Zhang; Yuhong Chen; Yupei Wang; Xuetian Zhang; Yang Liu; Chao Sun; Hong Zhang; Jörg D Hoheisel
Journal:  Cell Death Differ       Date:  2018-11-21       Impact factor: 15.828

Review 7.  Clusterin and Its Role in Insulin Resistance and the Cardiometabolic Syndrome.

Authors:  Jennifer Wittwer; David Bradley
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

Review 8.  The Influence of Clusterin Glycosylation Variability on Selected Pathophysiological Processes in the Human Body.

Authors:  Ewa Janiszewska; Agnieszka Kmieciak; Monika Kacperczyk; Aleksandra Witkowska; Ewa Maria Kratz
Journal:  Oxid Med Cell Longev       Date:  2022-08-28       Impact factor: 7.310

9.  Influenza A virus nucleoprotein induces apoptosis in human airway epithelial cells: implications of a novel interaction between nucleoprotein and host protein Clusterin.

Authors:  S Tripathi; J Batra; W Cao; K Sharma; J R Patel; P Ranjan; A Kumar; J M Katz; N J Cox; R B Lal; S Sambhara; S K Lal
Journal:  Cell Death Dis       Date:  2013-03-28       Impact factor: 8.469

10.  DNA methylation analysis on purified neurons and glia dissects age and Alzheimer's disease-specific changes in the human cortex.

Authors:  Gilles Gasparoni; Sebastian Bultmann; Pavlo Lutsik; Theo F J Kraus; Sabrina Sordon; Julia Vlcek; Vanessa Dietinger; Martina Steinmaurer; Melanie Haider; Christopher B Mulholland; Thomas Arzberger; Sigrun Roeber; Matthias Riemenschneider; Hans A Kretzschmar; Armin Giese; Heinrich Leonhardt; Jörn Walter
Journal:  Epigenetics Chromatin       Date:  2018-07-25       Impact factor: 4.954

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.